Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Wang, L. Tao, G. Shi, H. Wan, X. Cai, H. Zhu (Shanghai, China). Daytime risk factors of nocturnal hyoxemia in COPD patients unqualified for long-term oxygen therapy. Eur Respir J 2012; 40: Suppl. 56, 2910

Member's Comments

No comment yet.

Related content which might interest you: Prevalence,determinants and impact of nocturnal hypoxemia in COPD patients not candidates for domiciliary oxygen therapy Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Predictors of nocturnal desaturation in COPD patients with mild daytime hypoxaemia Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003 Nocturnal hypercapnia and oxygen therapy in COPD patients Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Benefits of long-term oxygen therapy among COPD patients with moderate resting desaturation Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Usefulness of daytime arterial blood gases in detection of nocturnal respiratory acidosis in COPD patients undergoing LTOT Source: Eur Respir J 2002; 20: Suppl. 38, 86s Year: 2002 Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Persistent daytime hypercapnia predicts poor prognosis in OSAS undergoing CPAP therapy Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016 Does long-term oxygen therapy reduce hospitalisation in hypoxaemic COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 274s Year: 2001 Domiciliary ambulatory oxygen is not beneficial in patients with COPD and mild resting hypoxaemia Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 PaO2 during exercise as a predictor for in-flight hypoxemia in COPD patients Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation Source: Eur Respir J 2001; 17: 848-855 Year: 2001 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Prevalence and contributing factors for daytime and nocturnal hypoxia in chronic heart failure patients Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Predicting response to oxygen therapy in obstructive sleep apnoea patients using a 10-minute daytime test Source: Eur Respir J, 51 (1) 1701587; 10.1183/13993003.01587-2017 Year: 2018 Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patients Source: ERJ Open Res, 6 (2) 00101-2019; 10.1183/23120541.00101-2019 Year: 2020 Factors predicting nocturnal hypoxemia in severe COPD with and without nutritional depletion Source: Eur Respir J 2002; 20: Suppl. 38, 499s Year: 2002 Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Source: Eur Respir J 2002; 20: 38-42 Year: 2002 Predictors of nocturnal hypoxaemia in COPD patients with arterial oxygen tensions above 60 mmHg Source: Eur Respir J 2001; 18: Suppl. 33, 87s Year: 2001